Based on ONCOMINE and GEPIA2 analyses, Prayugo et al. found that the expression of the FABP1 and FABP6 genes was significantly increased in CRC, and different tumor stages of CRC were related to the expression levels of FABP3 and FABP4 mRNA [97, 98]. This evidence concerns the gene FABP6 and colorectal carcinoma.